Compare BridgeBio Pharma Inc (BBIO) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Pinterest Inc — how do they compare? BridgeBio Pharma Inc trades at $82.83 (market cap $16.46B), while Pinterest Inc trades at $23.03 (market cap $12.66B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | PINS | |
|---|---|---|
Market Cap | $16.46B | $12.66B |
Sector | Health | Media |
52-Week High | $90.17 | $39.17 |
52-Week Low | $44.81 | $15.42 |
Enterprise Value | $18.02B | $12.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BridgeBio Pharma (BBIO) trades at $83.08, down 3.27% today, near its 52-week high. The stock shows bullish technical momentum with strong moving averages, while fundamentals reveal rapid revenue growth to $502M in 2025 but persistent losses with a -144.4% net margin. Recent news highlights regulatory approvals for acoramidis and a $1B preferred equity raise to fund launches, driving positive sentiment despite earnings misses.
Outlook remains speculative with high execution risk; analyst consensus is strongly bullish (92% buy) targeting $104.57, but profitability challenges and heavy cash burn require successful pipeline commercialization to justify valuation. Key near-term catalysts include FDA decisions on BBP-418 and encaleret in 2026.
Pinterest (PINS) trades at $22.6, up 0.31% on the day, with a bullish technical outlook and strong analyst consensus. Revenue grew to $4.22B in 2025, with net income of $417M, though Q2 2026 earnings are pending. Recent news highlights AI-driven shopping features and user growth, supporting positive sentiment.
The stock offers upside to the $27.72 consensus target, but high valuation ratios and recent insider selling pose risks. Earnings consistency and competitive pressures in social media remain key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
